The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Bray, Jonathan Leslie
    Company Secretary born in July 1950
    Individual (1 offspring)
    Officer
    2013-10-04 ~ now
    OF - Director → CIF 0
    Bray, Jonathan Leslie
    Company Secretary
    Individual (1 offspring)
    Officer
    2002-12-10 ~ now
    OF - Secretary → CIF 0
  • 2
    Bray, Dorothy Helen, Dr
    Immunologist born in November 1955
    Individual (6 offsprings)
    Officer
    2002-12-10 ~ now
    OF - Director → CIF 0
  • 3
    2, Royal College Street, London, England
    Corporate (1 offspring)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
Ceased 6
  • 1
    Thomas, Mark
    Individual
    Officer
    2000-05-31 ~ 2002-12-11
    OF - Secretary → CIF 0
  • 2
    Luciene James Limited
    Individual
    Officer
    2000-01-26 ~ 2000-01-26
    OF - Nominee Director → CIF 0
  • 3
    Bray, Jonathan
    Director
    Individual (1 offspring)
    Officer
    2000-01-26 ~ 2002-12-10
    OF - Director → CIF 0
  • 4
    Rouzel, Alan Keith
    Individual (33 offsprings)
    Officer
    2000-01-26 ~ 2000-06-05
    OF - Secretary → CIF 0
  • 5
    7972 Forest City Road, Orlando, Fl 32810, 7972 Forest City Road, Orlando, Florida, United States
    Corporate
    Person with significant control
    2019-05-07 ~ 2022-01-23
    PE - Ownership of shares – 75% or more as a member of a firmCIF 0
    PE - Has significant influence or controlCIF 0
  • 6
    RACHEL FUTERMAN LIMITED - 1996-04-01
    83, Leonard Street, London
    Active Corporate (1 parent, 7 offsprings)
    Equity (Company account)
    2 GBP2024-07-31
    Officer
    2000-01-26 ~ 2000-01-26
    PE - Nominee Secretary → CIF 0
parent relation
Company in focus

IMMUNOCLIN LIMITED

Previous names
IMMUNOCLIN LABORATORIES LIMITED - 2002-08-02
IMMUNOVA LABORATORIES LIMITED - 2000-06-22
Standard Industrial Classification
21200 - Manufacture Of Pharmaceutical Preparations
71200 - Technical Testing And Analysis
72110 - Research And Experimental Development On Biotechnology
Brief company account
Property, Plant & Equipment
50,486 GBP2024-02-29
5,545 GBP2023-02-28
Fixed Assets
50,486 GBP2024-02-29
5,545 GBP2023-02-28
Debtors
15,128 GBP2024-02-29
41,235 GBP2023-02-28
Cash at bank and in hand
70,000 GBP2024-02-29
5,113 GBP2023-02-28
Current Assets
85,128 GBP2024-02-29
46,348 GBP2023-02-28
Creditors
Amounts falling due within one year
-346,006 GBP2024-02-29
-295,148 GBP2023-02-28
Net Current Assets/Liabilities
-260,878 GBP2024-02-29
-248,800 GBP2023-02-28
Total Assets Less Current Liabilities
-210,392 GBP2024-02-29
-243,255 GBP2023-02-28
Net Assets/Liabilities
-210,392 GBP2024-02-29
-243,255 GBP2023-02-28
Equity
Called up share capital
10,000 GBP2024-02-29
10,000 GBP2023-02-28
Retained earnings (accumulated losses)
-220,392 GBP2024-02-29
-253,255 GBP2023-02-28
Equity
-210,392 GBP2024-02-29
-243,255 GBP2023-02-28
Average Number of Employees
02023-03-01 ~ 2024-02-29
02022-03-01 ~ 2023-02-28
Property, Plant & Equipment - Gross Cost
352,842 GBP2024-02-29
325,270 GBP2023-02-28
Property, Plant & Equipment - Disposals
-19,965 GBP2023-03-01 ~ 2024-02-29
Property, Plant & Equipment - Accumulated Depreciation & Impairment
302,356 GBP2024-02-29
319,725 GBP2023-02-28
Property, Plant & Equipment - Increase From Depreciation Charge for Year
737 GBP2023-03-01 ~ 2024-02-29
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
-19,965 GBP2023-03-01 ~ 2024-02-29
Property, Plant & Equipment - Other increase or decrease in the depreciation or impairment
1,859 GBP2023-03-01 ~ 2024-02-29

  • IMMUNOCLIN LIMITED
    Info
    IMMUNOCLIN LABORATORIES LIMITED - 2002-08-02
    IMMUNOVA LABORATORIES LIMITED - 2000-06-22
    Registered number 03914021
    2 Royal College Street, London NW1 0NH
    Private Limited Company incorporated on 2000-01-26 (25 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2024-07-26
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.